K
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Kanishka Manna's research focuses on the application of multi-omics data integration and proteogenomic analysis to understand complex biological systems. Manna has investigated the regulatory features of triple-negative breast cancer and identified alterations associated with acquired resistance to targeted therapies in melanoma patient-derived xenografts. This work involves the development and application of proteogenomic reference database protocols. Manna's research also extends to studying the effects of short-term metformin treatment on gut microbiota composition in models of obese liver steatosis. Manna has published six papers and has a current h-index of 2 with 21 citations. Manna collaborates with researchers at the University of Arkansas for Medical Sciences, including Michael Scott Robeson, Charity L. Washam, Duah Alkam, and Samuel G. Mackintosh.
Metrics
- h-index: 2
- Publications: 6
- Citations: 21
Selected Publications
-
Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy (2023)
-
Proteogenomics Reference Database Protocol v1 (2022)
-
Proteogenomics Reference Database Protocol v1 (2022)
-
Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model (2022)
-
Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy (2022)
-
Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer (2021)
Collaboration Network
Top Collaborators
Stephanie D. Byrum
University of Arkansas for Medical Sciences
6 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
Showing 5 of 6 shared publications
Charity L. Washam
University of Arkansas for Medical Sciences
5 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Duah Alkam
University of Arkansas for Medical Sciences
5 shared publications
In database
- Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Michael S. Robeson
University of Arkansas for Medical Sciences
5 shared publications
In database
- Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Prashanthi Dharanipragada
University of California, Los Angeles (US)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Nathan L. Avaritt
University of Arkansas for Medical Sciences
4 shared publications
In database
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Samuel G. Mackintosh
University of Arkansas for Medical Sciences
4 shared publications
In database
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Zhentao Yang
University of California, Los Angeles (US)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Shirley H. Lomeli
University of California, Los Angeles (US)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Gatien Moriceau
Oldham Council (GB)
4 shared publications
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Alan J. Tackett
University of Arkansas for Medical Sciences
4 shared publications
In database
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Tung-Chin Chiang
University of Arkansas for Medical Sciences
3 shared publications
In database
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Roger S. Lo
University of California, Los Angeles (US)
3 shared publications
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Ricky D. Edmondson
University of Arkansas for Medical Sciences
2 shared publications
In database
- Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy
- Proteogenomics Analysis to Identify Acquired Resistance-Specific Alterations in Melanoma PDXs on MAPKi Therapy
Richard J. Edmondson
University of Arkansas at Little Rock (US)
2 shared publications
- Proteogenomics Reference Database Protocol v1
- Proteogenomics Reference Database Protocol v1
Similar Researchers
Based on overlapping research topics
Nathan L. Avaritt
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Studies
Gut microbiota and health
Michael J. Birrer
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Studies
Cancer Treatment and Pharmacology
Kevin Chappell
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Studies
Bioinformatics and Genomic Networks
Orwa Aboud
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Studies
Cancer Treatment and Pharmacology
Emilie Darrigues
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Cancer Treatment and Pharmacology
Bioinformatics and Genomic Networks
Alan J. Tackett
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Metabolomics and Mass Spectrometry Studies
Cancer Treatment and Pharmacology